MBT
CLB icon

Monroe Bank & Trust’s Core Laboratories CLB Stock Holding History

Monroe Bank & Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$462K Sell
8,845
-824
-9% -$48.3K 0.15% 79
2019
Q1 		$666K Buy
9,669
+2,280
+31% +$153K 0.21% 69
2018
Q4 		$441K Sell
7,389
-2,526
-25% -$218K 0.15% 76
2018
Q3 		$1.15M Buy
9,915
+74
+0.8% +$8.35K 0.35% 51
2018
Q2 		$1.24M Sell
9,841
-38
-0.4% -$4.63K 0.38% 47
2018
Q1 		$1.07M Buy
9,879
+444
+5% +$49.1K 0.34% 52
2017
Q4 		$1.03M Buy
9,435
+15
+0.2% +$1.5K 0.32% 56
2017
Q3 		$930K Buy
9,420
+235
+3% +$22.8K 0.31% 56
2017
Q2 		$930K Buy
9,185
+130
+1% +$14K 0.31% 57
2017
Q1 		$1.05M Sell
9,055
-95
-1% -$11K 0.35% 52
2016
Q4 		$1.1M Sell
9,150
-423
-4% -$46.8K 0.38% 51
2016
Q3 		$928K Sell
9,573
-209
-2% -$24.1K 0.34% 57
2016
Q2 		$1.21M Buy
9,782
+23
+0.2% +$2.78K 0.42% 48
2016
Q1 		$1.1M Buy
9,759
+419
+4% +$43.5K 0.38% 58
2015
Q4 		$1.02M Buy
9,340
+130
+1% +$14.9K 0.37% 65
2015
Q3 		$919K Sell
9,210
-226
-2% -$24.6K 0.34% 69
2015
Q2 		$1.08M Buy
9,436
+395
+4% +$47.9K 0.36% 63
2015
Q1 		$945K Sell
9,041
-689
-7% -$73.4K 0.33% 74
2014
Q4 		$1.17M Buy
9,730
+581
+6% +$76.3K 0.4% 66
2014
Q3 		$1.34M Sell
9,149
-1,180
-11% -$182K 0.49% 47
2014
Q2 		$1.73M Sell
10,329
-147
-1% -$26.2K 0.57% 41
2014
Q1 		$2.08M Buy
10,476
+175
+2% +$33K 0.69% 35
2013
Q4 		$1.97M Sell
10,301
-77
-0.7% -$14.3K 0.77% 33
2013
Q3 		$1.76M Buy
10,378
+600
+6% +$93.1K 0.72% 35
2013
Q2 		$1.48M Buy
+9,778
New +$1.39M 0.66% 40

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Monroe Bank & Trust's CLB Position: Q2 2019 in Review

Monroe Bank & Trust reduced its Core Laboratories (CLB) stake by 8.5% in Q2 2019, selling an estimated $48.3K and leaving 8,845 shares worth $462K. The position accounts for 0.15% of the portfolio, ranked #79.

Monroe Bank & Trust first reported a position in CLB in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.08M in Q1 2014. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

  • Monroe Bank & Trust held 8,845 shares of Core Laboratories worth $462K as of Q2 2019.
  • Monroe Bank & Trust sold 824 Core Laboratories shares in Q2 2019, an estimated $48.3K.
  • Core Laboratories made up 0.15% of Monroe Bank & Trust's portfolio in Q2 2019, its #79 holding.
  • Monroe Bank & Trust first reported a position in Core Laboratories in Q2 2013 and has held it in 25 quarters since.
  • Monroe Bank & Trust's Core Laboratories position peaked at $2.08M in Q1 2014.
  • 304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Monroe Bank & Trust's 13F filing for Q2 2019, filed 29 Jul 2019.